Meet Our Candidates: Felicia Chew for Tucson City Council Ward 3

The Arizona primary election will be held on August 29, 2017. Reproductive health care access has been under attack, both nationally and statewide, but Planned Parenthood Advocates of Arizona has endorsed candidates who have shown strong commitment to reproductive justice. In order to vote in the primary election, you must be registered to vote by July 31 (today!). Early voting begins on August 2. Make your voice heard in 2017!

Felicia Chew was the first candidate to enter the race for Tucson’s Ward 3 after its long-serving councilwoman, Karin Uhlich, announced last year that she would not seek reelection. Ms. Chew has served her community as a teacher for more than 20 years, most recently at Mansfeld Middle School, and has also been active in the community as an advocate for mental health, environmental sustainability, and education. Now Chew is seeking to enter politics as a new way to be a voice for her neighbors and community, including those who are too often underrepresented, as the city councilwoman for Ward 3, which covers the city’s northwest area.


“I will never stop fighting for reproductive rights and health care for all Tucsonans.”


Planned Parenthood Advocates of Arizona announced its endorsement of Felicia Chew earlier this month, and Ms. Chew generously took time for an interview with us on July 25, 2017, to tell us more about her background and her campaign.

Tell us a little about your background.

I am a first-generation Chinese-American daughter of immigrant parents. I am a teacher, a single mother, and an advocate. I’ve been a teacher for over 20 years and have always taught my students about how to be responsible citizens, complex thinkers, and effective communicators. As a survivor of domestic violence, I want to ensure survivors in Tucson have all the resources they need. As a single mom, I want to help working families like mine by implementing and expanding programs that make our lives better. I am running for city council to advocate for and amplify the voices of my neighbors and each of us in Tucson. Continue reading

Pro-Choice Friday News Rundown

  • John McCainJohn McCain, Lisa Murkowski, and Susan Collins broke from the degenerate cretins of the GOP and helped DEFEAT the repeal of Obamacare. I can’t believe I’m typing this. (CNN)
  • As we’ve all said umpteen times, the GOP succeeding at defunding Planned Parenthood would have overwhelmed other clinics and left women with few options — which is the opposite of what anyone with a heart should want. (WaPo)
  • An interesting new study of 358 gay male couples showed that HIV-positive men who are on treatment that makes the virus undetectable do not transmit HIV to their partners during condomless anal intercourse. (NBC News)
  • ICYMI: No. 45’s administration is cutting funding for teen pregnancy prevention and 148 members of Congress are demanding answers. I doubt they’ll get them, but appreciate the effort. (Rewire)
  • As a black woman, this broke my heart and seared my soul: The No. 1 cause of death among black women under 35 is intimate partner violence. Men are killing us. Frequently. Brutally. (The Root)
  • Proenza Schouler did a video love note to Planned Parenthood. I dig it. (The Cut)
  • Did you know that since since January, 49 states have introduced almost 600 pieces of legislation to protect and advance access to reproductive health care services?! (Elle)
  • The controversy over the effects of Essure (a permanent method of sterilization for women) continues to rage on. (WaPo)
  • When it comes to trying to undercut women’s access to reproductive heath care, Texas will not S T O P. (Guttmacher)
  • They also passed their unconscionable “bathroom bill.” Ugh. (The Daily Beast)
  • Another state choosing to burden women with more abortion restrictions? Missouri. Like Texas, they’re becoming notorious for this crap. (Jezebel)

Why Do Newborns Need the Hepatitis B Vaccine?

The first vaccine a baby receives — within hours or days of birth — protects them from hepatitis B virus (HBV). In a lot of people’s minds, HBV is associated with drug use and sexual activity — which stigmatizes people who have been infected with HBV or are carriers of the virus. Unfortunately, this stigma causes a lot of people to question why babies even need to be vaccinated against it, often pointing to “Big Pharma” conspiracy theories. A lot of other people are put off by the misconception that the HBV vaccine is made with human blood (it’s not).


May is Hepatitis Awareness Month, a time to learn about a childhood vaccine that’s saved millions of lives.


There are perfectly good reasons to vaccinate babies against HBV, mainly that HBV is the leading cause of liver cancer, itself one of the Top 10 types of cancer worldwide. Nine out of 10 infants born to a mother who is an HBV carrier will develop chronic infections and become carriers themselves — and a quarter of them will die prematurely of liver disease. Babies who develop chronic HBV infections are 63 times more likely to develop liver cancer than non-carriers, a connection that is 2 to 3 times stronger than the link between smoking and lung cancer.

When it comes to HBV, age at infection matters. Most people with chronic HBV infections are exposed at birth or in early childhood, when they are most likely to develop chronic, lifelong infections — whereas only 2 to 6 percent of infected adults will develop chronic infections, with only 15 percent of them eventually dying from liver disease. The fact that chronic infection risk is inversely correlated with age at infection means that birth is the time when a child is the most vulnerable to this virus — hence the importance of vaccinating as early as possible. Continue reading

STD Awareness: Human Papillomavirus Grabs Headlines

Human papillomavirus, or HPV, is the most common STD out there — a fact made even more aggravating by the absence of a good test for it. Sure, Pap testing can detect cellular abnormalities triggered by HPV, and the HPV DNA test can find evidence of infection. But it’s not a definitive test — a negative Pap/HPV DNA co-test doesn’t rule out the possibility that you carry the virus. Ditto for the anal Pap test — which most people haven’t even heard of anyway!


There are more compelling reasons to vaccinate boys against HPV — and not-as-compelling reasons to think Gardasil could protect against skin cancer.


The lack of a good diagnostic test makes the HPV vaccine an even more valuable asset. If we can drive the virus to extinction through aggressive vaccination campaigns, our limited diagnostic abilities become a moot point. And recent headlines have given us reasons to love the HPV vaccine even more.

HPV and Men

Many people think of HPV as a women’s issue, as the virus causes cervical cancer, and for a long time, boys and men weren’t even targeted for vaccination. But HPV is everyone’s issue — genital warts don’t care what gender you are, and cancer-causing strains of HPV cause most cases of anal cancer, penile cancer, and oropharyngeal cancer. Recently, a large, first-of-its kind study published in JAMA Oncology analyzed penile swabs provided by 1,757 men to figure out how common HPV is in this population. (While there is no FDA-approved test for diagnosing male patients with HPV, scientists can still collect swabs for research purposes.)

The results: 45.2 percent of American men ages 18 to 59 carry genital HPV — for a total of nearly 35 million adult males. HPV carriers can transmit the virus to sexual partners through vaginal, anal, or oral sex — or even just rubbing genitals together, as the virus is spread by skin-to-skin contact. Furthermore, a quarter of men are infected with cancer-causing strains of HPV. And, while the female population sees a peak in HPV infections in their early 20s, men’s HPV prevalence increases with age. While 28.9 percent of men 18 to 22 years of age carried HPV, 50.8 percent of them carried it by the time they were 28 to 32 years of age, and 59.7 percent of 58- and 59-year-olds were carriers. Continue reading

Ovarian Cancer, Endometrial Cancer, and the Pill

birth-control-pillsThe most popular method of birth control in the United States is the Pill, followed by tubal ligation (permanent sterilization, or getting your tubes tied) and condoms. The Pill is a hormonal method of contraception, while sterilization and condoms are nonhormonal. The distinction between hormonal and nonhormonal methods of birth control are simply that the former contain synthetic versions of human hormones, while the latter do not.


By suppressing ovulation and thinning the uterine lining, the Pill can reduce risk of ovarian and endometrial cancers.


Glands in our bodies, called endocrine glands, produce hormones; additionally, testes and ovaries — which are parts of the human reproductive system — manufacture hormones. Human hormones are powerful chemicals, which do all sorts of jobs, from triggering puberty to helping us extract energy from the foods we eat. So it’s not a huge stretch to wonder if exposure to the hormones present in certain birth control methods — such as the Pill, in addition to the patch, the ring, the shot, the implant, and some types of IUDs — might have unintended effects on the body. Because hormones can play a role in cancer — either in protecting against it or aiding in its development — researchers are very interested to know if the Pill might increase or decrease risk for various types of cancer.

It’s actually a bit tricky to investigate the possible associations between the Pill and various types of cancer. First of all, there are dozens of types of birth control pills, all with different versions of synthetic hormones, at different dosages, and in different proportions to one another. Furthermore, the types of oral contraceptives on the market change over time — today’s birth control pill is not your mother’s birth control pill. Studying “the Pill” as a single entity could obscure differences between brands. Secondly, most cancers tend to develop later in life, many years after someone may have taken oral contraceptives. Researchers need to be careful to control for all the variables that might increase or decrease cancer risk. Continue reading

STD Awareness: Two Out of Three Ain’t Bad

For the past decade, human papillomavirus, better known as HPV, has been a pretty consistent headline grabber. Formerly a little-discussed virus, HPV was catapulted into the public consciousness in 2006, when suddenly people were all aflutter about this cancer-causing sexually transmitted pathogen, as well as Gardasil, the three-shot vaccination series the Centers for Disease Control and Prevention was recommending to preteen girls as protection from cervical cancer.


Kids 14 and younger develop such a strong immune response to Gardasil that they only need two doses — not three!


Dialogue has evolved since then, as people have recognized that HPV causes more than just cervical cancer — including anal cancer, head-and-neck cancer, and penile cancer — meaning that all children should be vaccinated, not just girls. And fears that the vaccine will “encourage” promiscuity still abound, despite thorough scientific debunking. In fact, many experts believe that our skittishness surrounding sexuality — especially when it comes to teenagers — causes parents to turn a blind eye to the importance of vaccinating their children against HPV. (Unvaccinated children might not appreciate their parents’ choice, if, say, a few years down the line they find a smattering of genital warts below their belts.)

Ongoing scientific research into Gardasil and the virus it protects against provides continuous fodder for journalists covering medical and scientific advances. Here are just a few of the most recent headlines featuring HPV:

Continue reading

STD Awareness: Is Chlamydia Bad?

chlamydiaPerhaps your sexual partner has informed you that they have been diagnosed with chlamydia, and you need to get tested, too. Maybe you’ve been notified by the health department that you might have been exposed to chlamydia. And it’s possible that you barely know what chlamydia even is, let alone how much you should be worried about it.

Chlamydia is one of the most common sexually transmitted diseases (STDs) out there, especially among young people. It can be spread by oral, vaginal, and anal sex, particularly when condoms or dental dams were not used correctly or at all. It is often a “silent” infection, meaning that most people with chlamydia don’t experience symptoms — you can’t assume you don’t have it because you feel fine, and you can’t assume your partner doesn’t have it because they look fine. If you’re sexually active, the best way to protect yourself is to know your partner’s STD status and to practice safer sex.


Chlamydia increases risk for HIV, leads to fertility and pregnancy problems, and might increase cancer risk.


The good news about chlamydia is that it’s easy to cure — but first, you need to know you have it! And that’s why it’s important for sexually active people to receive regular STD screening. Left untreated, chlamydia can increase risk of acquiring HIV, can hurt fertility in both males and females, can be harmful during pregnancy, and might even increase risk for a certain type of cancer. So why let it wreak havoc on your body when you could just get tested and take a quick round of antibiotics?

To find out just how seriously you should take chlamydia, let’s answer a few common questions about it.

Can Chlamydia Increase HIV Risk?

Chlamydia does not cause HIV. Chlamydia is caused by a type of bacteria, while HIV is a virus that causes a fatal disease called AIDS. However, many STDs, including chlamydia, can increase risk for an HIV infection, meaning that someone with an untreated chlamydia infection is more likely to be infected with HIV if exposed to the virus. Continue reading